mtlumby2d Chapter 670
Chapter 670
……
After everyone accepted the news, Chen Xuan spoke again, "If you are interested in this drug, you can pay attention to the upcoming clinical trials. We will disclose the entire clinical trial process in real time."
Shengyuan medicine is different from restoring eye drops.
The effect of the eye drops is immediate and everyone can see the results directly.
But it is different for bio-sourced drugs. Their indications are all various chronic diseases, so there is no way to display them directly.
You can't find a gout patient on the spot and ask him to try the biosource medicine to demonstrate the treatment effect. There is no point in doing so.
Therefore, Chen Xuan did not prepare any trial sessions, but simply introduced the indications and displayed some test data.
However, the range of indications of Shengyuan Medicine also left everyone stunned.
This new drug has too many indications, and they are all common diseases with very high prevalence rates, belonging to a very large group of people.
Simply put, the market for biogenic drugs is likely to be a market of more than 10 billion people, or even a huge market of far more than 10 billion people.
It is indeed incredible that just one drug can cover such an amazing group of patients, but it also shows the huge potential.
"Chen Xuan is so awesome."
"Hiss, if these effects can be realized, then this market will be amazing."
"Mr. Chen never makes false claims or exaggerates, and its effectiveness is often better than advertised."
"That's right. As long as Mr. Chen says it himself, you can rest assured."
"This drug still needs clinical trials. We'll know whether it's effective or not then. You don't have to worry. Just wait and see the results of the clinical trials."
"The market potential for biogenic drugs is huge. I think it's no less than that for restoring vision eye drops."
"I suddenly understand why Mr. Chen said Antai Pharmaceutical Group is worth $4000 billion. It's really worth that much, and there's no exaggeration at all."
Although most of the people present were laymen, they could also see the market for bio-sourced medicines.
If this therapeutic effect can be achieved, then this medicine will definitely become a monopoly.
At this time, everyone completely understood what Chen Xuan had said before about the valuation of Antai Pharmaceutical Group.
Before, people thought it was exaggerated and that $4000 billion was unrealistic, but after the two drugs were unveiled one after another, everything seemed so reasonable.
"Both new drug applications for clinical trials have been approved."
"From today, clinical trials will officially begin, and clinical trials will be conducted for various indications."
"By then, all the results of the clinical trials will be made public in real time. If you are interested, you can keep an eye on them and you are welcome to raise questions."
Chen Xuan spoke again, "I'm very happy that everyone is supervising new drugs and raising reasonable questions. This is the only way to ensure the safety of new drugs and make them better."
Having said that, it also means that the new drug introduction session has come to an end.
But at the end, he did not forget to imply something about Amit.
He can accept reasonable supervision and questioning, but not the same groundless questioning as the latter.
"Mr. Chen!"
"The Phase III clinical trials of the pancreatic cancer drug and the self-love drug have both been successfully completed, and the clinical performance has exceeded expectations."
"Will these two new drugs be launched soon? Has your group planned the launch date for these two drugs?"
At this time, Bingbing raised these two questions in a timely manner.
Although both biogenic medicine and restoring eye drops are important, they are also medical achievements that shocked the world.
But the most urgent task is to find effective drugs for pancreatic cancer and self-love drugs.
After all, the first two drugs have just been developed and even the first phase of clinical trials has not yet begun. It will definitely take a long time for them to be truly launched on the market.